Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mesh:Practice Guidelines as Topic"" wg kryterium: Temat


Tytuł :
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists].
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Autorzy :
Loriot, Marie-Anne
Masskouri, Fadil
Carni, Paolo
Le Malicot, Karine
Seitz, Jean-François
Michel, Pierre
Legoux, Jean-Louis
Bouche, Olivier
André, Thierry
Faroux, Roger
Delaloge, Suzette
Malka, David
Guigay, Joël
Thariat, Juliette
Thomas, Fabienne
Barin-Le-Guellec, Chantal
Ciccolini, Joseph
Boyer, Jean-Christophe
Etienne-Grimaldi, Marie-Christine
Pokaż więcej
Temat :
DPD
Dihydropyrimidine dehydrogenase
Dihydropyrimidine déshydrogénase
Dépistage
Enquête
Fluoropyrimidine
Screening
Surveys
Toxicity
Toxicité
MESH: Antimetabolites, Antineoplastic
MESH: Antineoplastic Combined Chemotherapy Protocols
MESH: Female
MESH: Fluorouracil
MESH: France
MESH: Genotype
MESH: Health Care Surveys
MESH: Humans
MESH: Oncologists
MESH: Otorhinolaryngologic Neoplasms
MESH: Pharmacovigilance
MESH: Practice Guidelines as Topic
MESH: Pyrimidines
MESH: Reimbursement Mechanisms
MESH: Biology
MESH: Biomedical Research
MESH: Breast Neoplasms
MESH: Capecitabine
MESH: Digestive System Neoplasms
MESH: Dihydropyrimidine Dehydrogenase Deficiency
[SDV]Life Sciences [q-bio]
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Tytuł :
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists].
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Autorzy :
Loriot, Marie-Anne
Masskouri, Fadil
Carni, Paolo
Le Malicot, Karine
Seitz, Jean-François
Michel, Pierre
Legoux, Jean-Louis
Bouche, Olivier
André, Thierry
Faroux, Roger
Delaloge, Suzette
Malka, David
Guigay, Joël
Thariat, Juliette
Thomas, Fabienne
Barin-Le-Guellec, Chantal
Ciccolini, Joseph
Boyer, Jean-Christophe
Etienne-Grimaldi, Marie-Christine
Pokaż więcej
Temat :
DPD
Dihydropyrimidine dehydrogenase
Dihydropyrimidine déshydrogénase
Dépistage
Enquête
Fluoropyrimidine
Screening
Surveys
Toxicity
Toxicité
MESH: Antimetabolites, Antineoplastic
MESH: Antineoplastic Combined Chemotherapy Protocols
MESH: Female
MESH: Fluorouracil
MESH: France
MESH: Genotype
MESH: Health Care Surveys
MESH: Humans
MESH: Oncologists
MESH: Otorhinolaryngologic Neoplasms
MESH: Pharmacovigilance
MESH: Practice Guidelines as Topic
MESH: Pyrimidines
MESH: Reimbursement Mechanisms
MESH: Biology
MESH: Biomedical Research
MESH: Breast Neoplasms
MESH: Capecitabine
MESH: Digestive System Neoplasms
MESH: Dihydropyrimidine Dehydrogenase Deficiency
[SDV]Life Sciences [q-bio]
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Tytuł :
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists].
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Autorzy :
Loriot, Marie-Anne
Masskouri, Fadil
Carni, Paolo
Le Malicot, Karine
Seitz, Jean-François
Michel, Pierre
Legoux, Jean-Louis
Bouche, Olivier
André, Thierry
Faroux, Roger
Delaloge, Suzette
Malka, David
Guigay, Joël
Thariat, Juliette
Thomas, Fabienne
Barin-Le-Guellec, Chantal
Ciccolini, Joseph
Boyer, Jean-Christophe
Etienne-Grimaldi, Marie-Christine
Pokaż więcej
Temat :
DPD
Dihydropyrimidine dehydrogenase
Dihydropyrimidine déshydrogénase
Dépistage
Enquête
Fluoropyrimidine
Screening
Surveys
Toxicity
Toxicité
MESH: Antimetabolites, Antineoplastic
MESH: Antineoplastic Combined Chemotherapy Protocols
MESH: Female
MESH: Fluorouracil
MESH: France
MESH: Genotype
MESH: Health Care Surveys
MESH: Humans
MESH: Oncologists
MESH: Otorhinolaryngologic Neoplasms
MESH: Pharmacovigilance
MESH: Practice Guidelines as Topic
MESH: Pyrimidines
MESH: Reimbursement Mechanisms
MESH: Biology
MESH: Biomedical Research
MESH: Breast Neoplasms
MESH: Capecitabine
MESH: Digestive System Neoplasms
MESH: Dihydropyrimidine Dehydrogenase Deficiency
[SDV]Life Sciences [q-bio]
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Tytuł :
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists].
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Autorzy :
Loriot, Marie-Anne
Masskouri, Fadil
Carni, Paolo
Le Malicot, Karine
Seitz, Jean-François
Michel, Pierre
Legoux, Jean-Louis
Bouche, Olivier
André, Thierry
Faroux, Roger
Delaloge, Suzette
Malka, David
Guigay, Joël
Thariat, Juliette
Thomas, Fabienne
Barin-Le-Guellec, Chantal
Ciccolini, Joseph
Boyer, Jean-Christophe
Etienne-Grimaldi, Marie-Christine
Pokaż więcej
Temat :
DPD
Dihydropyrimidine dehydrogenase
Dihydropyrimidine déshydrogénase
Dépistage
Enquête
Fluoropyrimidine
Screening
Surveys
Toxicity
Toxicité
MESH: Antimetabolites, Antineoplastic
MESH: Antineoplastic Combined Chemotherapy Protocols
MESH: Female
MESH: Fluorouracil
MESH: France
MESH: Genotype
MESH: Health Care Surveys
MESH: Humans
MESH: Oncologists
MESH: Otorhinolaryngologic Neoplasms
MESH: Pharmacovigilance
MESH: Practice Guidelines as Topic
MESH: Pyrimidines
MESH: Reimbursement Mechanisms
MESH: Biology
MESH: Biomedical Research
MESH: Breast Neoplasms
MESH: Capecitabine
MESH: Digestive System Neoplasms
MESH: Dihydropyrimidine Dehydrogenase Deficiency
[SDV]Life Sciences [q-bio]
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Tytuł :
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients with Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Autorzy :
Thabut, Dominique
Bureau, Christophe
Layese, Richard
Mahuas-Bourcier, Valerie
Hammouche, Maryam
Cagnot, Carole
Marcellin, Patrick
Guyader, Dominique
Pol, Stanislas
Larrey, Dominique
De Ledinghen, Victor
Ouzan, Denis
Zoulim, Fabien
Roulot, Dominique
Tran, Albert
Bronowicki, Jean-Pierre
Zarski, Jean-Pierre
Goria, Odile
Cales, Paul
Peron, Jean-Marie
Alric, Laurent
Bourliere, Marc
Mathurin, Philippe
Blanc, Jean-Frederic
Abergel, Armand
Serfaty, Lawrence
Mallat, Ariane
Grange, Jean-Didier
Attali, Pierre
Bacq, Yannick
Wartelle-Bladou, Claire
Dao, Thong
Pilette, Christophe
Silvain, Christine
Christidis, Christos
Capron, Dominique
Bernard-Chabert, Brigitte
Hillaire, Sophie
Di Martino, Vincent
Sutton, Angela
Audureau, Etienne
Roudot-Thoraval, Francoise
Nahon, Pierre
Fontaine, Helene
Leroy, Vincent
Riachi, Ghassan
Dharancy, Sebastien
Thiefin, Gerard
Pokaż więcej
Temat :
Sciences du Vivant [q-bio]
Portal Hypertension
Variceal Bleeding
Esophagus
Elastometry
Mesh:Hepatitis C
Mesh:Chronic/drug therapy
Mesh:Hypertension
Mesh:Portal/etiology
Mesh:Liver Cirrhosis/complications
Mesh:Liver Cirrhosis/diagnostic imaging
Mesh:Liver Cirrhosis/physiopathology
Mesh:Liver Cirrhosis/virology
Mesh:Male
Mesh:Mass Screening/standards
Mesh:Middle Aged
Mesh:Platelet Count
Mesh:Population Surveillance
Mesh:Practice Guidelines as Topic
Mesh:Survival Rate
Mesh:Sustained Virologic Response
Mesh:Antiviral Agents/therapeutic use
Mesh:Disease Progression
Mesh:Elasticity Imaging Techniques
Mesh:Endoscopy
Mesh:Gastrointestinal
Mesh:Esophageal and Gastric Varices/diagnostic imaging
Mesh:Esophageal and Gastric Varices/etiology
Mesh:Female
Mesh:Hepatitis B
Mesh:Chronic/complications
Mesh:Humans
Tytuł :
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
Autorzy :
Mantovani, Giovanna
Bastepe, Murat
Monk, David
De Sanctis, Luisa
Thiele, Susanne
Usardi, Alessia
Ahmed, S Faisal
Bufo, Roberto
Choplin, Timothée
De Filippo, Gianpaolo
Devernois, Guillemette
Eggermann, Thomas
Elli, Francesca
Freson, Kathleen
García Ramirez, Aurora
Germain-Lee, Emily
Groussin, Lionel
Hamdy, Neveen
Hanna, Patrick
Hiort, Olaf
Jüppner, Harald
Kamenicky, Peter
Knight, Nina
Kottler, Marie-Laure
Le Norcy, Elvire
Lecumberri, Beatriz
Levine, Michael
Mäkitie, Outi
Martin, Regina
Martos-Moreno, Gabriel Ángel
Minagawa, Masanori
Murray, Philip
Pereda, Arrate
Pignolo, Robert
Rejnmark, Lars
Rodado, Rebecca
Rothenbuhler, Anya
Saraff, Vrinda
Shoemaker, Ashley
Shore, Eileen
Silve, Caroline
Turan, Serap
Woods, Philip
Zillikens, M Carola
Perez De Nanclares, Guiomar
Linglart, Agnès
Pokaż więcej
Temat :
MESH: Consensus
MESH: Delayed Diagnosis
MESH: Practice Guidelines as Topic
MESH: Prognosis
MESH: Program Development
MESH: Pseudohypoparathyroidism
MESH: Risk Assessment
MESH: Drug Resistance
MESH: Female
MESH: Genetic Predisposition to Disease
MESH: Humans
MESH: Infant, Newborn
MESH: Male
MESH: Neonatal Screening
MESH: Parathyroid Hormone
[SDV.GEN]Life Sciences [q-bio]/Genetics
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
Źródło :
Nature Reviews Endocrinology
Nature Reviews Endocrinology, Nature Publishing Group, 2018, 14 (8), pp.476-500. ⟨10.1038/s41574-018-0042-0⟩
Tytuł :
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
Autorzy :
Mantovani, Giovanna
Bastepe, Murat
Monk, David
De Sanctis, Luisa
Thiele, Susanne
Usardi, Alessia
Ahmed, S Faisal
Bufo, Roberto
Choplin, Timothée
De Filippo, Gianpaolo
Devernois, Guillemette
Eggermann, Thomas
Elli, Francesca
Freson, Kathleen
García Ramirez, Aurora
Germain-Lee, Emily
Groussin, Lionel
Hamdy, Neveen
Hanna, Patrick
Hiort, Olaf
Jüppner, Harald
Kamenicky, Peter
Knight, Nina
Kottler, Marie-Laure
Le Norcy, Elvire
Lecumberri, Beatriz
Levine, Michael
Mäkitie, Outi
Martin, Regina
Martos-Moreno, Gabriel Ángel
Minagawa, Masanori
Murray, Philip
Pereda, Arrate
Pignolo, Robert
Rejnmark, Lars
Rodado, Rebecca
Rothenbuhler, Anya
Saraff, Vrinda
Shoemaker, Ashley
Shore, Eileen
Silve, Caroline
Turan, Serap
Woods, Philip
Zillikens, M Carola
Perez De Nanclares, Guiomar
Linglart, Agnès
Pokaż więcej
Temat :
MESH: Consensus
MESH: Delayed Diagnosis
MESH: Practice Guidelines as Topic
MESH: Prognosis
MESH: Program Development
MESH: Pseudohypoparathyroidism
MESH: Risk Assessment
MESH: Drug Resistance
MESH: Female
MESH: Genetic Predisposition to Disease
MESH: Humans
MESH: Infant, Newborn
MESH: Male
MESH: Neonatal Screening
MESH: Parathyroid Hormone
[SDV.GEN]Life Sciences [q-bio]/Genetics
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
Źródło :
Nature Reviews Endocrinology
Nature Reviews Endocrinology, Nature Publishing Group, 2018, 14 (8), pp.476-500. ⟨10.1038/s41574-018-0042-0⟩
Tytuł :
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
Autorzy :
Mantovani, Giovanna
Bastepe, Murat
Monk, David
De Sanctis, Luisa
Thiele, Susanne
Usardi, Alessia
Ahmed, S Faisal
Bufo, Roberto
Choplin, Timothée
De Filippo, Gianpaolo
Devernois, Guillemette
Eggermann, Thomas
Elli, Francesca
Freson, Kathleen
García Ramirez, Aurora
Germain-Lee, Emily
Groussin, Lionel
Hamdy, Neveen
Hanna, Patrick
Hiort, Olaf
Jüppner, Harald
Kamenicky, Peter
Knight, Nina
Kottler, Marie-Laure
Le Norcy, Elvire
Lecumberri, Beatriz
Levine, Michael
Mäkitie, Outi
Martin, Regina
Martos-Moreno, Gabriel Ángel
Minagawa, Masanori
Murray, Philip
Pereda, Arrate
Pignolo, Robert
Rejnmark, Lars
Rodado, Rebecca
Rothenbuhler, Anya
Saraff, Vrinda
Shoemaker, Ashley
Shore, Eileen
Silve, Caroline
Turan, Serap
Woods, Philip
Zillikens, M Carola
Perez De Nanclares, Guiomar
Linglart, Agnès
Pokaż więcej
Temat :
MESH: Consensus
MESH: Delayed Diagnosis
MESH: Practice Guidelines as Topic
MESH: Prognosis
MESH: Program Development
MESH: Pseudohypoparathyroidism
MESH: Risk Assessment
MESH: Drug Resistance
MESH: Female
MESH: Genetic Predisposition to Disease
MESH: Humans
MESH: Infant, Newborn
MESH: Male
MESH: Neonatal Screening
MESH: Parathyroid Hormone
[SDV.GEN]Life Sciences [q-bio]/Genetics
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
Źródło :
Nature Reviews Endocrinology
Nature Reviews Endocrinology, Nature Publishing Group, 2018, 14 (8), pp.476-500. ⟨10.1038/s41574-018-0042-0⟩
Tytuł :
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
Autorzy :
Mantovani, Giovanna
Bastepe, Murat
Monk, David
De Sanctis, Luisa
Thiele, Susanne
Usardi, Alessia
Ahmed, S Faisal
Bufo, Roberto
Choplin, Timothée
De Filippo, Gianpaolo
Devernois, Guillemette
Eggermann, Thomas
Elli, Francesca
Freson, Kathleen
García Ramirez, Aurora
Germain-Lee, Emily
Groussin, Lionel
Hamdy, Neveen
Hanna, Patrick
Hiort, Olaf
Jüppner, Harald
Kamenicky, Peter
Knight, Nina
Kottler, Marie-Laure
Le Norcy, Elvire
Lecumberri, Beatriz
Levine, Michael
Mäkitie, Outi
Martin, Regina
Martos-Moreno, Gabriel Ángel
Minagawa, Masanori
Murray, Philip
Pereda, Arrate
Pignolo, Robert
Rejnmark, Lars
Rodado, Rebecca
Rothenbuhler, Anya
Saraff, Vrinda
Shoemaker, Ashley
Shore, Eileen
Silve, Caroline
Turan, Serap
Woods, Philip
Zillikens, M Carola
Perez De Nanclares, Guiomar
Linglart, Agnès
Pokaż więcej
Temat :
MESH: Consensus
MESH: Delayed Diagnosis
MESH: Practice Guidelines as Topic
MESH: Prognosis
MESH: Program Development
MESH: Pseudohypoparathyroidism
MESH: Risk Assessment
MESH: Drug Resistance
MESH: Female
MESH: Genetic Predisposition to Disease
MESH: Humans
MESH: Infant, Newborn
MESH: Male
MESH: Neonatal Screening
MESH: Parathyroid Hormone
[SDV.GEN]Life Sciences [q-bio]/Genetics
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
Źródło :
Nature Reviews Endocrinology
Nature Reviews Endocrinology, Nature Publishing Group, 2018, 14 (8), pp.476-500. ⟨10.1038/s41574-018-0042-0⟩
Tytuł :
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
Autorzy :
Mantovani, Giovanna
Bastepe, Murat
Monk, David
De Sanctis, Luisa
Thiele, Susanne
Usardi, Alessia
Ahmed, S Faisal
Bufo, Roberto
Choplin, Timothée
De Filippo, Gianpaolo
Devernois, Guillemette
Eggermann, Thomas
Elli, Francesca
Freson, Kathleen
García Ramirez, Aurora
Germain-Lee, Emily
Groussin, Lionel
Hamdy, Neveen
Hanna, Patrick
Hiort, Olaf
Jüppner, Harald
Kamenicky, Peter
Knight, Nina
Kottler, Marie-Laure
Le Norcy, Elvire
Lecumberri, Beatriz
Levine, Michael
Mäkitie, Outi
Martin, Regina
Martos-Moreno, Gabriel Ángel
Minagawa, Masanori
Murray, Philip
Pereda, Arrate
Pignolo, Robert
Rejnmark, Lars
Rodado, Rebecca
Rothenbuhler, Anya
Saraff, Vrinda
Shoemaker, Ashley
Shore, Eileen
Silve, Caroline
Turan, Serap
Woods, Philip
Zillikens, M Carola
Perez De Nanclares, Guiomar
Linglart, Agnès
Pokaż więcej
Temat :
MESH: Consensus
MESH: Delayed Diagnosis
MESH: Practice Guidelines as Topic
MESH: Prognosis
MESH: Program Development
MESH: Pseudohypoparathyroidism
MESH: Risk Assessment
MESH: Drug Resistance
MESH: Female
MESH: Genetic Predisposition to Disease
MESH: Humans
MESH: Infant, Newborn
MESH: Male
MESH: Neonatal Screening
MESH: Parathyroid Hormone
[SDV.GEN]Life Sciences [q-bio]/Genetics
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
Źródło :
Nature Reviews Endocrinology
Nature Reviews Endocrinology, Nature Publishing Group, 2018, 14 (8), pp.476-500. ⟨10.1038/s41574-018-0042-0⟩
Tytuł :
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-time Adjusted Survival of Patients With Compensated Viral Cirrhosis.
Autorzy :
Costentin, Charlotte
Layese, Richard
Bourcier, Valerie
Cagnot, Carole
Marcellin, Patrick
Guyader, Dominique
Pol, Stanislas
Larrey, Dominique
De Ledinghen, Victor
Ouzan, Denis
Zoulim, Fabien
Roulot, Dominique
Tran, Albert
Bronowicki, Jean-Pierre
Zarski, Jean-Pierre
Riachi, Ghassan
Cales, Paul
Peron, Jean-Marie
Alric, Laurent
Bourliere, Marc
Mathurin, Philippe
Blanc, Jean-Frederic
Abergel, Armand
Serfaty, Lawrence
Mallat, Ariane
Grange, Jean-Didier
Attali, Pierre
Bacq, Yannick
Wartelle, Claire
Dao, Thong
Thabut, Dominique
Pilette, Christophe
Silvain, Christine
Christidis, Christos
Nguyen-Khac, Eric
Bernard-Chabert, Brigitte
Zucman, David
Di Martino, Vincent
Sutton, Angela
Letouze, Eric
Imbeaud, Sandrine
Zucman-Rossi, Jessica
Audureau, Etienne
Roudot-Thoraval, Francoise
Nahon, Pierre
Pokaż więcej
Temat :
Mesh:Liver Cirrhosis/therapy
Mesh:Hepatitis B virus/isolation & purification
Mesh:Liver Neoplasms/mortality
Mesh:Liver Neoplasms/therapy
Mesh:Liver/diagnostic imaging
Mesh:Humans
Mesh:Early Detection of Cancer/statistics & numerical data
Mesh:Hepacivirus/isolation & purification
Mesh:Aged
Mesh:Practice Guidelines as Topic
Mesh:Prospective Studies
Mesh:Follow-Up Studies
Mesh:Liver/pathology
Mesh:Guideline Adherence/statistics & numerical data
Mesh:Carcinoma
Mesh:Hepatocellular/diagnostic imaging
Mesh:Middle Aged
Mesh:Liver Cirrhosis/diagnostic imaging
Mesh:France/epidemiology
Mesh:Hepatocellular/therapy
Mesh:Liver Neoplasms/diagnostic imaging
Mesh:Liver Neoplasms/virology
Mesh:Liver Cirrhosis/mortality
Mesh:Early Detection of Cancer/standards
Mesh:Multivariate Analysis
Mesh:Kaplan-Meier Estimate
Mesh:Liver Cirrhosis/virology
Mesh:Hepatocellular/mortality
Mesh:Antiviral Agents/therapeutic use
Mesh:Hepatocellular/virology
Mesh:Female
Mesh:Male
Curative Treatment
Screening
Liver Cancer
Early Detection
Sciences du Vivant [q-bio]

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies